AAMU
VIE

Amundi Asset Management US’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Amundi Asset Management US’s Portfolio VIE Stock Details VIE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,100
Closed -$221K – 1675
2020
Q2 		$221K Sell
5,100
-100
-2% -$4.53K ﹤0.01% 1370
2020
Q1 		$198K Buy
+5,200
New +$203K ﹤0.01% 1334

Other funds holding VIE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Amundi Asset Management US's VIE Position: Q3 2020 in Review

Amundi Asset Management US sold out of Viela Bio, Inc. Common Stock (VIE) in Q3 2020, closing a stake of 5,100 shares — an estimated $221K sold.

Amundi Asset Management US first reported a position in VIE in Q1 2020 and held it in 2 quarters. The position peaked at $221K in Q2 2020. 60 funds tracked by Wall St. Rank hold VIE as of Q3 2020.

  • Amundi Asset Management US reported no remaining Viela Bio, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Amundi Asset Management US sold 5,100 Viela Bio, Inc. Common Stock shares in Q3 2020, an estimated $221K.
  • Amundi Asset Management US first reported a position in Viela Bio, Inc. Common Stock in Q1 2020 and held it in 2 quarters.
  • Amundi Asset Management US's Viela Bio, Inc. Common Stock position peaked at $221K in Q2 2020.
  • 60 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q3 2020.

Based on Amundi Asset Management US's 13F filing for Q3 2020, filed 16 Nov 2020.